The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 10X GENOMICS INC | CL A COM | 88025U109 | BBG007WX14Y9 | 10,884,220 | 194,500 | SH | SOLE | 194,500 | 0 | 0 | ||
| ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | BBG001V0GG18 | 8,269,559 | 1,687,665 | SH | SOLE | 1,687,665 | 0 | 0 | ||
| AKOYA BIOSCIENCES INC | COM | 00974H104 | BBG00JX4LRX4 | 22,925,191 | 4,697,785 | SH | SOLE | 4,697,785 | 0 | 0 | ||
| GUARDANT HEALTH INC | COM | 40131M109 | BBG006D97VZ8 | 15,446,821 | 571,047 | SH | SOLE | 571,047 | 0 | 0 | ||
| MAXCYTE INC | COM | 57777K106 | BBG00CFTQNG7 | 8,859,500 | 1,885,000 | SH | SOLE | 1,885,000 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | BBG001TG36G6 | 1,311,115 | 1,751,891 | SH | SOLE | 1,751,891 | 0 | 0 | ||
| NATERA INC | COM | 632307104 | BBG001V0FSF8 | 24,895,391 | 397,436 | SH | SOLE | 397,436 | 0 | 0 | ||
| QUANTERIX CORP | COM | 74766Q101 | BBG0027NWC78 | 7,879,279 | 288,196 | SH | SOLE | 288,196 | 0 | 0 | ||
| THERMO FISHER SCIENTIFIC INC | COM | 883556102 | BBG001S5WS08 | 13,694,382 | 25,800 | SH | SOLE | 25,800 | 0 | 0 | ||